Development of a genotype 325-specific proCPU/TAFI ELISA

被引:77
作者
Gils, A
Alessi, MC
Brouwers, E
Peeters, M
Marx, P
Leurs, J
Bouma, B
Hendriks, D
Juhan-Vague, I
Declerck, PJ
机构
[1] Katholieke Univ Leuven, Fac Pharmaceut Sci, Lab Pharmaceut Biol & Phytopharmacol, B-3000 Louvain, Belgium
[2] CHU Timone, INSERM, EPI 9936, Haematol Lab, Marseille, France
[3] Univ Med Ctr Utrecht, Dept Haematol, Utrecht, Netherlands
[4] Univ Antwerp, Med Biochem Lab, Antwerp, Belgium
关键词
TAFI; proCPU; monoclonal antibody; ELISA; genotype dependent;
D O I
10.1161/01.ATV.0000074145.58172.BD
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-A Thr/Ile polymorphism at position 325 in the coding region of proCPU has been reported. Immunological assays, fully characterized (including genotype dependency), are required for the quantitation of proCPU levels. Methods and Results-We have generated a panel of monoclonal antibodies against human, plasma-derived proCPU. Two combinations exhibiting distinct reactivities were selected for measurement of proCPU in plasma. T12D11/T28G6-HRP yielded values of 10.1 +/- 3.1 mug/mL (mean +/- SD, n = 86; normal donors), and T32F6/T9G12-HRP yielded values of 5.4 +/- 3.0 mug/mL. Grouping according to the 325 genotype demonstrated that T12D11/T28G6-HRP was independent to this polymorphism whereas T32F6/T9G12-HRP revealed a complete lack of reactivity with the Ile/Ile genotype (ie, 0.0 +/- 0.0, 4.2 +/- 1.7, and 7.3 +/- 2.9 mug/mL for the Ile/Ile, Ile/Thr, and Thr/Thr isoforms, respectively). Commercially available antigen assays appeared to be partially dependent on the 325 genotype (eg, 44 +/- 8.9% and 100 +/- 30% for the Ile/Ile and Thr/Thr isoforms, respectively). Conclusions-Our data demonstrate that great care should be taken when evaluating proCPU antigen values as a putative causative agent or as a diagnostic risk marker for cardiovascular events.
引用
收藏
页码:1122 / 1127
页数:6
相关论文
共 32 条
  • [1] INDUCTION OF PLASMA CELL TUMOURS IN BALB/C MICE WITH 2,6,10,14-TETRAMETHYLPENTADECANE (PRISTANE)
    ANDERSON, PN
    POTTER, M
    [J]. NATURE, 1969, 222 (5197) : 994 - &
  • [2] PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR
    BAJZAR, L
    MANUEL, R
    NESHEIM, ME
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) : 14477 - 14484
  • [3] The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent
    Bajzar, L
    Nesheim, ME
    Tracy, PB
    [J]. BLOOD, 1996, 88 (06) : 2093 - 2100
  • [4] Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B)
    Boffa, MB
    Reid, TS
    Joo, E
    Nesheim, ME
    Koschinsky, ML
    [J]. BIOCHEMISTRY, 1999, 38 (20) : 6547 - 6558
  • [5] Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties
    Boffa, MB
    Wang, W
    Bajzar, L
    Nesheim, ME
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) : 2127 - 2135
  • [6] Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor
    Boffa, MB
    Bell, R
    Stevens, WK
    Nesheim, ME
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (17) : 12868 - 12878
  • [7] A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels
    Brouwers, GJ
    Vos, HL
    Leebeek, FWG
    Bulk, S
    Schneider, M
    Boffa, M
    Koschinsky, M
    van Tilburg, NH
    Nesheim, ME
    Bertina, RM
    García, EBG
    [J]. BLOOD, 2001, 98 (06) : 1992 - 1993
  • [8] Plasma TAFI antigen variations in healthy subjects
    Chetaille, P
    Alessi, MC
    Kouassi, D
    Morange, PE
    Juhan-Vague, I
    [J]. THROMBOSIS AND HAEMOSTASIS, 2000, 83 (06) : 902 - 905
  • [9] EATON DL, 1991, J BIOL CHEM, V266, P21833
  • [10] ISOLATION OF PURE IGG1, IGG2A AND IGG2B IMMUNOGLOBULINS FROM MOUSE SERUM USING PROTEIN A-SEPHAROSE
    EY, PL
    PROWSE, SJ
    JENKIN, CR
    [J]. IMMUNOCHEMISTRY, 1978, 15 (07): : 429 - 436